Compounding Risk Alert
To alert health care professionals of adverse event reports related to compounded drugs
- Protect patients from unsafe, ineffective, and poor quality compounded drugs
Recent posts
- Hemorrhagic Occlusive Retinal Vasculitis (HORV) Following Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin Formulation
- Adverse Events associated with Guardian’s compounded triamcinolone and moxifloxacin product for intravitreal injection
- Two serious adverse events associated with ImprimisRx’s compounded curcumin emulsion product for injection
Image credit: FDA